HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics

• Published in: Open access Macedonian journal of medical sciences Vol. 6; no. 7; pp. 1187 - 1192
• Main Authors: Ognjenovic, Ljubomir, Trajkovski, Gjorgji, Gjoshev, Stojan, Shumkovski, Aleksandar, Dzambaz, Darko, Hadzi-Manchev, Dragan, Volcevski, Goce, Fildishevski, Igor, Nikolova, Dafina, Petrushevska, Gordana, Janevska, Vesna, Janevski, Vlado
• Format: Journal Article
• Language: English
• Published: Macedonia Republic of Macedonia 20-07-2018
• Subjects: Basic Science; HER2 expression; immunohistochemistry; TNM classification; gastric cancer; tumour grade
• ISSN: 1857-9655; 1857-9655
• DOI: 10.3889/oamjms.2018.280

HER2 protein expression in gastric carcinoma, in correlation with existing, acknowledged prognostic factors which include the parameters that determine the TNM stage of the disease, could become the basis for ongoing research in the field of molecular targeted and personalised therapy.
To determine the expression of the HER2 protein in gastric carcinoma and to correlate the expression of a HER2 protein with clinicopathological characteristics of the disease.
The data of HER2 protein expression and the parameters of the TNM classification were obtained from the histopathological reports of the Institute of Pathology in Skopje, and for the clinical stage we used patient's files from the University Clinic for Abdominal Surgery in Skopje.
The analysis of the correlation of HER2 protein expression and TNM classification parameters pointed out a significant correlation between HER2 protein expression and intragastric localisation of gastric carcinoma (P = 0.005), and the tumour grade of differentiation (P = 0.034). There was also a positive correlation between HER2 protein expression pattern and positive lymph nodes in patients with gastric carcinoma (P = 0.03). The expression pattern of HER2 +++ was significantly more common registered in patients with positive lymph nodes (P = 0.03).
The expression of HER2 protein could represent a biological marker with prognostic and predictive value in patients with gastric carcinoma. Considering the high mortality rate in patients with gastric carcinoma and lack of international standardised therapeutic approach, research of the role and significance of HER2 overexpression and Trastuzumab therapy may prove useful in the development of new therapeutic strategies.